June 2012 Drug Information Update - Pharmacy Benefits ...

More documents

Recommendations

Info

2011 on a temporary basis. Product will become available in stages as production resumes. • Bedford Laboratories has temporarily suspended the distribution of Ben Venue Laboratories manufactured products. Availability of products is updated on the Bedford Laboratories website. • Hospira has dacarbazine on shortage due to manufacturing delays. • APP has dacarbazine on shortage due to increased demand for the product. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=653 Source website: www.ashp.org Aztreonam Injection May 7, 2012 Products Affected - Description Aztreonam injection Reason for the Shortage • BMS acquired Azactam from Elan in April, 2010. • APP has increased production of aztreonam and is releasing product regularly to help • meet increased demand. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=888 Source website: www.ashp.org Ampicillin Sulbactam May 7, 2012 Products Affected - Description Ampicillin Sulbactam powder for injection, Hospira 1.5 gram vial, 10 count (NDC 00409-2988-01) 1.5 gram ADD-Vantage vial, 10 count (NDC 00409-2689-01) 3 gram vial, 10 count (NDC 00409-2998-03) 3 gram ADD-Vantage vial, 10 count (NDC 00409-2987-03) 3 gram Novaplus vial, 10 count (NDC 00409-2987-13) 15 gram bulk vial, 1 count (NDC 00409-2687-15) Unasyn powder for injection, Pfizer 1.5 gram Add-Vantage vial, 10 count (NDC 00049-0031-83) - discontinued 1.5 gram bottles, 10 count (NDC 00049-0022-83) - discontinued 3 gram ADD-Vantage vial, 10 count (NDC 00049-0032-83) - discontinued 3 gram bottle, 10 count (NDC 00049-0023-83) - discontinued Ampicillin Sulbactam powder for injection, Sagent 3 gram vial, 10 count (NDC 25021-0143-30) 15 gram bulk vial, 1 count (NDC 25021-0144-99) Ampicillin Sulbactam powder for injection, West-Ward 1.5 gram vial, 10 count (NDC 10019-0631-01) – NDC discontinued 3 gram vial, 10 count (NDC 10019-0630-02) – NDC discontinued 15 gram bulk vial, 1 count (NDC 10019-0632-03) – NDC discontinued 1.5 gram vial, 10 count (NDC 00641-6116-10) 1.5 gram Novaplus vial, 10 count (NDC 10019-0636-01) 3 gram Novaplus vial, 10 count (NDC 10019-0637-02) 15 gram bulk vial, 1 count (NDC 00641-6118-01) 38
15 gram Novaplus bulk vial, 1 count (NDC 10019-0638-03) Reason for the Shortage • Hospira states that ampicillin sulbactam vials are on back order due to raw material shortages. • Sagent cannot provide a reason for the shortage. • Sandoz states the shortage was due to increased demand for the products. • Pfizer discontinued Unasyn 3 gram 10 count bottles in late, 2011. Pfizer discontinued all Unasyn Add-Vantage vials and bottles in early 2012. • West-Ward acquired several Baxter products in early 2011. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=805 Source website: www.ashp.org Amphetamine Mixed Salts, Extended-Release Capsules May 7, 2012 Products Affected - Description Amphetamine mixed salts extended-release capsules, Teva 30 mg capsules, 100 count (NDC 00555-0789-02) Amphetamine mixed salts extended-release capsules, Global Pharmaceuticals 5 mg capsules, 100 count (NDC 00115-1328-01) 10 mg capsules, 100 count (NDC 00115-1329-01) 15 mg capsules, 100 count (NDC 00115-1330-01) 20 mg capsules, 100 count (NDC 00115-1331-01) 25 mg capsules, 100 count (NDC 00115-1332-01) 30 mg capsules, 100 count (NDC 00115-1333-01) Reason for the Shortage • Teva cannot provide a reason for the shortage. • Global Pharmaceuticals states the shortage is due to increased demand. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=577 Source website: www.ashp.org Vinblastine Injection May 8, 2012 Products Affected - Description Vinblastine lyophilized powder for injection, Bedford 10 mg vial (NDC 55390-0091-10) Vinblastine sulfate injection, APP 1 mg/mL, 10 mL vial (NDC 63323-0278-10) Reason for the Shortage • Ben Venue voluntarily suspended all manufacturing and distribution in mid-November, 2011. Product will become available in stages as production resumes. • Bedford Laboratories has multiple products affected by this suspension of manufacturing. Availability of all products, including those not manufactured at Ben Venue, is updated as information changes on the Bedford Laboratories website. • APP has their product in short supply due to increased demand for the product and a manufacturing delay. Article link: http://www.ashp.org/DrugShortages/Current/Bulletin.aspx?id=883 Source website: www.ashp.org 39
Page 1 and 2: June 2012 Drug Information Update
Page 3 and 4: First-Time Generics GENERIC DRUG NA
Page 5 and 6: ANTI-DIARRHEALS OPIUM TINCTURE DISP
Page 7 and 8: indicated for the treatment of HIV-
Page 9 and 10: Source website: http://www.fda.gov/
Page 11 and 12: Testosterone Chases Viagra in Libid
Page 13 and 14: Analytical Trend Troubles Scientist
Page 15 and 16: Testosterone supplements may help m
Page 17 and 18: voted 19-3 to endorse the drug's us
Page 19 and 20: New Drug Trial Seeks to Stop Alzhei
Page 21 and 22: translates into a 38 percent reduct
Page 23 and 24: atypical fractures of the thigh bon
Page 25 and 26: contain Sibutramine, an appetite su
Page 27 and 28: 2 fl oz UPC 011673257424. Recall #
Page 29 and 30: NDC 5816082101 (single dose vial);
Page 31 and 32: Manufacturer: Catalent Argentina S.
Page 33 and 34: • Fera cannot provide a reason fo
Page 35 and 36: • Akorn states the reason for the
Page 37: Reason for the Shortage • Teva st
Page 41 and 42: Milrinone Injection May 9, 2012 Pro
Page 43 and 44: • Ranbaxy has all discontinued me
Page 45 and 46: Doxorubicin Liposomal Injection May
Page 47 and 48: 1 mg/mL, 2 mL vial, 25 count (NDC 6
Page 49 and 50: • APP has leucovorin on shortage
Page 51 and 52: • West-Ward acquired Baxter’s o
Page 53 and 54: • Ethinyl estradiol/norethindrone
Page 55 and 56: Potassium chloride for injection, H
Page 57 and 58: Labetalol tablets, Sandoz 100 mg, 1
Page 59 and 60: the gray market. • Ferring has No
Page 61 and 62: Source website: www.ashp.org Loraze
Page 63 and 64: Fentanyl Injection 50 mcg/mL, Hospi
Page 65 and 66: Bupivacaine Injection May 17, 2012
Page 67 and 68: Article link: http://www.ashp.org/D
Page 69 and 70: Heparin Sodium Injection May 18, 20
Page 71 and 72: o Heparin sodium 10 unit/mL, 5 mL l
Page 73 and 74: Article link: http://www.ashp.org/D
Page 75 and 76: • Amphastar and Baxter have disco
Page 77 and 78: Fludarabine Injection May 21, 2012
Page 79 and 80: TheraCys Intravesical Injection, Sa
Page 81 and 82: Nystatin Oral Suspension May 22, 20
Page 83 and 84: discontinued the 1 mg/mL 4 mL vials
Page 85 and 86: 10 gram vial (NDC 63323-0314-61) Va
Page 87 and 88: 10 mg/mL, 10 mL vial (NDC 63323-020
Page 89 and 90:
Papaverine injection Reason for the
Page 91 and 92:
• Mylan Institutional (formerly B
Page 93 and 94:
20 mg, 100 count (NDC 00781-1695-01
Page 95 and 96:
4 mL vial (NDC 00641-6008-10) 10 mL
Page 97 and 98:
20 mL vials (NDC 00069-1340-02) Ond
Page 99 and 100:
ecently changed old Baxter to new W
Page 101 and 102:
1 mg/mL, 2 mL vial, 25 count (new N
Page 103 and 104:
250 mg, 100 count unit dose (NDC 00
Page 105 and 106:
Granisetron Hydrochloride Injection
Page 107 and 108:
15 mg/mL, 10 mL vial (NDC 63323-048
Page 109 and 110:
Ampicillin Sulbactam May 30, 2012 P
show all

June 2012 Drug Information Update - Pharmacy Benefits ...

Create successful ePaper yourself

Delete template?

Save as template?